Diagnostyka S.A.

zł 150.00As of Sun 8 Nov 2026, 12:00 UTC
WSE:DIAHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 2.93%
ROE 55.37%
Diagnostics & Research
Beta (5Y) —
PE TTM 19.87
TSR TTM (16.77%)
Mkt cap zł 5.063B
ROIC 18.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 180
20.30%
15.88%
Hold 1|8|6|5|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
1.53
1.67
1.63
1.58
12.94%
19.81%
19.60%
9.63%
Revenuezł M
469.8
463.2
462.6
481.1
2.84%
2.78%
(2.11%)
3.17%
Peers (US$1.279B)
Cap (US$)
PE
400.5M
13.58x
75.84M
—
1.285B
—
Capital
TTM
5Y
10Y
Leveragex
0.252
0.153
0.124
EBIT/Intx
5.670
0.658
0.650
Own earn%
3.88
40.67
42.08
Sh yield%
34.17
33.11
32.51
Owners
Insiders/Inst%
6.52
29.65
Short interest%
5.83
SBC / revenue%
5.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
24–31
$1 testx
−0.2
Incr. ROIC%
5